Supplementary Figure 1 from Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

Kelly J. Norsworthy,Flora Mulkey,Emma C. Scott,Ashley F. Ward, Donna Przepiorka,Rosane Charlab,Sarah E. Dorff,Albert Deisseroth,Dickran Kazandjian, Rajeshwari Sridhara,Julia A. Beaver, Ann T. Farrell,R. Angelo de Claro,Richard Pazdur

openalex

引用 0|浏览0

暂无评分

摘要

Supplementary Figure 1. Detailed flow diagram for ascertainment of DS cases.

更多

查看译文

关键词

Treatment Discontinuation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要